Tildren 5 mg/ml 10 x 10 ml

Avertissement : le produit sur la photo peut différer du produit réel.

SKU
M128
Marque:
Audevard
Batch:
108AA
Expiry date:
31-12-2026
Numéro d'enregistrement:
NL: REG NL 10079 - DE: ZNR 8-00564 - IT: AIC103601035 - FR: FR/V/7671510 7/2002 - Lux: V915/03/04/0750

Le numéro d’autorisation de mise sur le marché de votre pays ne pas répertorié ? Il s'agit alors d'un produit cascade. Cliquez ici pour plus d'informations.

En stock

Tiludronic acid (as the disodium salt) injectable for the treatment of bone and cartilage-related lameness such as that of Navicular Disease and Bone Spavin.

Tildren 5 mg/ml 10 x 10 ml

To aid in the treatment of lameness associated with osteolytic processes observed in bone spavin and in navicular syndrome of less than 6 months.

Composition

The powder contains: Tiludronic Acid (as disodium Acid) 50 mg.
The solvent vial contains: water for injection 10 ml.
The solution after reconstitution contains: Tiludronic acid 5 mg/m

Indications d'utilisation

0.1 mg of tiludronic acid per kg of body weight per day for 10 days by slow intravenous route, i.e. 1 ml per 50 kg of body weight per day of a reconstituted solution containing 5 mg/ml of tiludronic acid.

 

The reconstituted solution is obtained by adding under aseptic conditions the solvent to the powder and gently mixing them.

 

- The product should be administered over 20 to 30 seconds for 10 ml.

- The side of the site of injection must be alternated from day to day.

- The product should be used immediately and not stored after reconstitution.

- Do not exceed the recommended dosage.

Tiludronic acid 5 mg/ml
© 2024 Grovet B.V. All rights reserved.